查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2132313

重組疫苗CDMO市場規模、佔有率和趨勢分析報告：按疫苗、服務、表達平台、工作流程、治療領域、最終用途、地區和細分市場預測（2026-2033年）

Recombinant Vaccine CDMO Market Size, Share & Trends Analysis Report By Vaccine, By Service, By Expression Platform, By Workflow, By Therapeutic Area, By End-use, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 250 Pages | 商品交期: 2-10個工作天內

價格

重組疫苗CDMO市場概述

全球重組疫苗CDMO市場預計到2025年將達到56億美元，到2026年將成長到61億美元，到2033年將達到124億美元，2026年至2033年的複合年成長率為10.5%。

北美是市場的主要驅動力，預計到 2025 年將佔銷售額的 43.8%。市場成長的促進因素包括：對重組蛋白疫苗的需求不斷成長、疫苗開發平臺不斷擴大以及疫苗研發和生產業務外包程度的提高。

此外，對重組抗原表現、上游和下游製程、製劑、填充和包裝服務等方面的專業能力的需求日益成長，推動了CDMO服務的需求。重組表達系統、細胞株開發、製程最佳化、自動化和分析檢測方面的進步，正在提高生產效率、產品均一性和擴充性。

此外，由於疫苗研發活動的增加和重組蛋白技術的進步，疫苗產業近年來持續成長。針對不同感染疾病適應症的重組疫苗候選產品數量不斷成長，推動了對專業研發和生產能力的需求。這些產品需要可控的抗原表達、純化、製劑、分析表徵以及符合GMP規範的生產過程。因此，預計未來幾年重組疫苗開發平臺的擴展將增加對專業CDMO服務的需求。

此外，由於內部生產需要大量的技術專長、專用基礎設施和資金投入，許多製藥和生物技術公司擴大將重組疫苗的開發和生產外包給專業的合約研發生產機構（CDMO）。 CDMO提供製程開發、表達系統最佳化、規模化生產、GMP生產、分析測試、製劑配製以及灌裝和包裝服務。這種方式使疫苗研發公司能夠利用專業的生產能力，同時減少自建生產設施的需求。對於正在推進重組疫苗候選產品進入臨床開發階段並需要靈活生產能力的新興生技公司而言，這種趨勢尤其明顯。

目錄

第1章 研究方法和範圍

第2章執行摘要

第3章 重組疫苗CDMO市場：變數、趨勢與範圍

  • 市場譜系展望
  • 市場動態
  • 科技情勢
  • 定價模式分析
  • 關稅影響分析
  • 價值鏈分析
  • 市場分析工具

第4章 重組疫苗CDMO市場：依疫苗類型分類的估算與趨勢分析

  • 疫苗市場佔有率（2025 年和 2033 年）
  • 重組疫苗CDMO市場：疫苗波動分析
  • 2021年至2033年全球重組疫苗CDMO市場規模及疫苗類型趨勢分析。
  • 重組蛋白/次單位疫苗
  • 類病毒顆粒（VLP）疫苗
  • 重組病毒載體疫苗
  • 重組DNA/mRNA疫苗
  • 其他

第5章 重組疫苗CDMO市場：按服務類型分類的估算與趨勢分析

  • 按服務分類的市場佔有率，2025 年和 2033 年
  • 重組疫苗CDMO市場：按服務類型分類的趨勢分析
  • 全球重組疫苗CDMO市場：按服務分類的規模和趨勢分析，2021-2033年
  • 合約開發
    • 細胞株構建
    • 製程開發與最佳化
    • 分析測試和方法驗證
    • 規模擴大和技術轉移
  • 契約製造
    • API生產
    • 成品藥的生產
  • 包裝和標籤
  • 藥品法規
  • 其他

第6章 重組疫苗CDMO市場：基於表現平台的估算與趨勢分析

  • 按表達平台分類的市場佔有率（2025 年和 2033 年）
  • 全球重組疫苗CDMO市場：基於表現平台的波動分析
  • 全球重組疫苗CDMO市場規模及趨勢分析（依表現平台分類）（2021-2033年）
  • 哺乳動物細胞表達
  • 微生物表達
  • 基於細胞的表達
  • 植物來源的表達
  • 其他

第7章 重組疫苗CDMO市場：依工作流程分類的估算與趨勢分析

  • 按工作流程分類的市場佔有率，2025 年和 2033 年
  • 全球重組疫苗CDMO市場：依工作流程分類的趨勢分析
  • 全球重組疫苗CDMO市場：基於工作流程的規模和趨勢分析，2021-2033年
  • 臨床階段
  • 商業

第8章 重組疫苗CDMO市場：依治療領域分類的估算與趨勢分析

  • 按治療區域分類的市場佔有率，2025 年和 2033 年
  • 全球重組疫苗CDMO市場：按治療領域分類的趨勢分析
  • 全球重組疫苗CDMO市場：依治療領域分類的規模與趨勢分析（2021-2033年）
  • 感染疾病
  • 腫瘤學
  • 神經病變
  • 其他用途

第9章 重組疫苗CDMO市場：依最終用途分類的估算與趨勢分析

  • 按最終用途分類的市場佔有率，2025 年和 2033 年
  • 重組疫苗CDMO市場：依最終用途分類的趨勢分析
  • 全球重組疫苗CDMO市場：依最終用途分類的規模和趨勢分析（2021-2033年）
  • 製藥公司
  • 生技公司
  • 學術和研究機構
  • 其他

第10章 重組疫苗CDMO市場：區域估算與趨勢分析

  • 區域市場概覽
  • 重組疫苗CDMO市場：區域趨勢分析
  • 市場規模、預測與趨勢分析，2021-2033年
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 歐洲重組疫苗研發生產組織（CDMO）市場估算與預測，2021-2033年
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 亞太地區重組疫苗CDMO市場估算與預測，2021-2033年
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 2021-2033年拉丁美洲重組疫苗CDMO市場估算與預測
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • UAE
    • 科威特
    • 阿曼
    • 卡達

第11章 競爭格局

  • 參與企業概況
  • 公司市場分析
  • 公司分類
  • 策略規劃
  • 公司簡介列表
    • FUJIFILM Biotechnologies
    • WuXi Biologics
    • IDT Biologika
    • Lonza
    • Thermo Fisher Scientific（Patheon）
    • AGC Biologics
    • KBI Biopharma
    • Ajinomoto Bio-Pharma Services
    • Northway Biotech
    • Batavia Biosciences
    • Recipharm
    • 3P Biopharmaceuticals
    • Biofabri
    • Biological E. Limited
    • SK bioscience
Product Code: GVR-4-68041-013-4

Recombinant Vaccine CDMO Market Summary

The global recombinant vaccine CDMO market size was valued at USD 5.6 billion in 2025 and is projected to grow from USD 6.1 billion in 2026 to USD 12.4 billion by 2033, at a CAGR of 10.5% from 2026 to 2033. North America dominated the market, accounting for a revenue share of 43.8% in 2025. Market growth is driven by increasing demand for recombinant protein vaccines, expansion of vaccine development pipelines, and growing outsourcing of vaccine development and manufacturing activities.

Moreover, the need for specialized capabilities in recombinant antigen expression, upstream and downstream processing, formulation, and fill-finish services is increasing the demand for CDMO services. Technological advancements in recombinant expression systems, cell line development, process optimization, automation, and analytical testing are improving manufacturing efficiency, product consistency, and scalability.

Furthermore, the vaccine industry has witnessed continued growth in recent years, supported by increasing vaccine development activities and advances in recombinant protein technologies. The growing number of recombinant vaccine candidates across infectious disease indications is increasing demand for specialized development and manufacturing capabilities. These products require controlled antigen expression, purification, formulation, analytical characterization, and GMP-compliant manufacturing processes. Thus, the expansion of recombinant vaccine development pipelines is expected to increase demand for specialized CDMO services in the coming years.

In addition, several pharmaceutical and biotechnology companies are increasingly outsourcing recombinant vaccine development and manufacturing activities to specialized CDMOs due to the technical expertise, specialized infrastructure, and capital requirements associated with in-house production. CDMOs provide process development, expression system optimization, scale-up, GMP manufacturing, analytical testing, formulation, and fill-finish services. This approach enables vaccine developers to access specialized manufacturing capabilities while reducing the need to establish dedicated production facilities. The trend is particularly relevant among emerging biotechnology companies progressing recombinant vaccine candidates through clinical development and requiring flexible manufacturing capacity.

Global Recombinant Vaccine CDMO Market Report Segmentation

This report forecasts revenue growth at a country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global recombinant vaccine CDMO market report based on vaccine, service, expression platform, workflow, therapeutic area, end-use, and region:

  • Vaccine Outlook (Revenue, USD Billion, 2021 - 2033)
  • Recombinant Protein/Subunit Vaccines
  • Virus-Like Particle (VLP) Vaccines
  • Recombinant Viral Vector Vaccines
  • Recombinant DNA/mRNA-enabled Vaccines
  • Others
  • Service Outlook (Revenue, USD Billion, 2021 - 2033)
  • Contract Development
    • Cell Line Development
    • Process Development & Optimization
    • Analytical Testing & Method Validation
    • Scale-up & Tech Transfer
  • Contract Manufacturing
    • API Manufacturing
    • Finished Drug Products Manufacturing
  • Packaging and Labeling
  • Regulatory Affairs
  • Others
  • Expression Platform Outlook (Revenue, USD Billion, 2021 - 2033)
  • Mammalian Cell Expression
  • Microbial Expression
  • Cell-Based Expression
  • Plant-Based Expression
  • Others
  • Workflow (Revenue, USD Billion, 2021 - 2033)
  • Clinical
  • Commercial
  • Therapeutic Area (Revenue, USD Billion, 2021 - 2033)
  • Infectious Diseases
  • Oncology
  • Neurological Disorders
  • Other Applications
  • End-use Outlook (Revenue, USD Billion, 2021 - 2033)
  • Pharmaceutical Companies
  • Biotechnology Companies
  • Academic and Research Institutions
  • Others
  • Regional Outlook (Revenue, USD Billion, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Sweden
    • Norway
    • Denmark
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait
    • Oman
    • Qatar

Table of Contents

Chapter 1. Research Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Vaccine
    • 1.2.2. Service
    • 1.2.3. Expression Platform
    • 1.2.4. Workflow
    • 1.2.5. Therapeutic Area
    • 1.2.6. End Use
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
  • 1.5. Information Or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity Flow Analysis
    • 1.7.2. Top-Down Analysis
    • 1.7.3. Botton-Up Approach
    • 1.7.4. Multivariate Analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Abbreviations
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Recombinant Vaccine CDMO Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Technology Landscape
  • 3.4. Pricing Model Analysis
  • 3.5. Tariff Impact Analysis
  • 3.6. Value Chain Analysis
    • 3.6.1. Supply Trends
    • 3.6.2. Demand Trends
  • 3.7. Market Analysis Tools
    • 3.7.1. Porter's Five Force Analysis
    • 3.7.2. PESTEL Analysis

Chapter 4. Recombinant Vaccine CDMO Market: Vaccine Estimates & Trend Analysis

  • 4.1. Vaccine Market Share, 2025 & 2033
  • 4.2. Vaccine Segment Dashboard
  • 4.3. Recombinant Vaccine CDMO Market: Vaccine Movement Analysis
  • 4.4. Global Recombinant Vaccine CDMO Market Size & Trend Analysis, by Vaccine, 2021 to 2033 (USD Billion)
  • 4.5. Recombinant Protein/Subunit Vaccines
    • 4.5.1. Recombinant Protein/Subunit Vaccines Market Estimates & Forecasts, 2021 to 2033 (USD Billion)
  • 4.6. Virus-Like Particle (VLP) Vaccines
    • 4.6.1. Virus-Like Particle (VLP) Vaccines Market Estimates & Forecasts, 2021 to 2033 (USD Billion)
  • 4.7. Recombinant Viral Vector Vaccines
    • 4.7.1. Recombinant Viral Vector Vaccines Market Estimates & Forecasts, 2021 to 2033 (USD Billion)
  • 4.8. Recombinant DNA/mRNA-enabled Vaccines
    • 4.8.1. Recombinant DNA/mRNA-enabled Vaccines Market Estimates & Forecasts, 2021 to 2033 (USD Billion)
  • 4.9. Others
    • 4.9.1. Others Market Estimates & Forecasts, 2021 to 2033 (USD Billion)

Chapter 5. Recombinant Vaccine CDMO Market: Service Estimates & Trend Analysis

  • 5.1. Service Market Share, 2025 & 2033
  • 5.2. Service Segment Dashboard
  • 5.3. Recombinant Vaccine CDMO Market: Service Movement Analysis
  • 5.4. Global Recombinant Vaccine CDMO Market Size & Trend Analysis, by Service, 2021 to 2033 (USD Billion)
  • 5.5. Contract Development
    • 5.5.1. Contract Development Market Estimates & Forecasts, 2021 to 2033 (USD Billion)
    • 5.5.2. Cell Line Development
      • 5.5.2.1. Cell Line Development Market Estimates & Forecasts, 2021 to 2033 (USD Billion)
    • 5.5.3. Process Development & Optimization
      • 5.5.3.1. Process Development & Optimization Market Estimates & Forecasts, 2021 to 2033 (USD Billion)
    • 5.5.4. Analytical Testing & Method Validation
      • 5.5.4.1. Analytical Testing & Method Validation Market Estimates & Forecasts, 2021 to 2033 (USD Billion)
    • 5.5.5. Scale-up & Tech Transfer
      • 5.5.5.1. Scale-up & Tech Transfer Market Estimates & Forecasts, 2021 to 2033 (USD Billion)
  • 5.6. Contract Manufacturing
    • 5.6.1. Contract Manufacturing Market Estimates & Forecasts, 2021 to 2033 (USD Billion)
    • 5.6.2. API Manufacturing
      • 5.6.2.1. API Manufacturing Market Estimates & Forecasts, 2021 to 2033 (USD Billion)
    • 5.6.3. Finished Drug Products Manufacturing
      • 5.6.3.1. Finished Drug Products Manufacturing Market Estimates & Forecasts, 2021 to 2033 (USD Billion)
  • 5.7. Packaging and Labeling
    • 5.7.1. Packaging and Labeling Market Estimates & Forecasts, 2021 to 2033 (USD Billion)
  • 5.8. Regulatory Affairs
    • 5.8.1. Regulatory Affairs Market Estimates & Forecasts, 2021 to 2033 (USD Billion)
  • 5.9. Others
    • 5.9.1. Others Market Estimates & Forecasts, 2021 to 2033 (USD Billion)

Chapter 6. Recombinant Vaccine CDMO Market: Expression Platform Estimates & Trend Analysis

  • 6.1. Expression Platform Market Share, 2025 & 2033
  • 6.2. Expression Platform Segment Dashboard
  • 6.3. Global Recombinant Vaccine CDMO Market: Expression Platform Movement Analysis
  • 6.4. Global Recombinant Vaccine CDMO Market Size & Trend Analysis, by Expression Platform, 2021 to 2033 (USD Billion)
  • 6.5. Mammalian Cell Expression
    • 6.5.1. Mammalian Cell Expression Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
  • 6.6. Microbial Expression
    • 6.6.1. Microbial Expression Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
  • 6.7. Cell-Based Expression
    • 6.7.1. Cell-Based Expression Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
  • 6.8. Plant-Based Expression
    • 6.8.1. Plant-Based Expression Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
  • 6.9. Others
    • 6.9.1. Others Market Estimates & Forecasts, 2021 - 2033 (USD Billion)

Chapter 7. Recombinant Vaccine CDMO Market: Workflow Estimates & Trend Analysis

  • 7.1. Workflow Market Share, 2025 & 2033
  • 7.2. Workflow Platform Segment Dashboard
  • 7.3. Global Recombinant Vaccine CDMO Market: Workflow Movement Analysis
  • 7.4. Global Recombinant Vaccine CDMO Market Size & Trend Analysis, by Workflow, 2021 to 2033 (USD Billion)
  • 7.5. Clinical
    • 7.5.1. Clinical Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
  • 7.6. Commercial
    • 7.6.1. Commercial Market Estimates & Forecasts, 2021 - 2033 (USD Billion)

Chapter 8. Recombinant Vaccine CDMO Market: Therapeutic Area Estimates & Trend Analysis

  • 8.1. Therapeutic Area Market Share, 2025 & 2033
  • 8.2. Therapeutic Area Segment Dashboard
  • 8.3. Global Recombinant Vaccine CDMO Market: Therapeutic Area Movement Analysis
  • 8.4. Global Recombinant Vaccine CDMO Market Size & Trend Analysis, by Therapeutic Area, 2021 to 2033 (USD Billion)
  • 8.5. Infectious Diseases
    • 8.5.1. Infectious Diseases Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
  • 8.6. Oncology
    • 8.6.1. Oncology Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
  • 8.7. Neurological Disorders
    • 8.7.1. Neurological Disorders Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
  • 8.8. Other Applications
    • 8.8.1. Other Applications Market Estimates & Forecasts, 2021 - 2033 (USD Billion)

Chapter 9. Recombinant Vaccine CDMO Market: End Use Estimates & Trend Analysis

  • 9.1. End Use Market Share, 2025 & 2033
  • 9.2. End Use Segment Dashboard
  • 9.3. Recombinant Vaccine CDMO Market: End Use Movement Analysis
  • 9.4. Global Recombinant Vaccine CDMO Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Billion)
  • 9.5. Pharmaceutical Companies
    • 9.5.1. Pharmaceutical Companies Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
  • 9.6. Biotechnology Companies
    • 9.6.1. Biotechnology Companies Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
  • 9.7. Academic and Research Institutions
    • 9.7.1. Academic and Research Institutions Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
  • 9.8. Others
    • 9.8.1. Others Market Estimates & Forecasts, 2021 - 2033 (USD Billion)

Chapter 10. Recombinant Vaccine CDMO Market: Regional Estimates & Trend Analysis

  • 10.1. Regional Market Dashboard
  • 10.2. Recombinant Vaccine CDMO Market: Regional Movement Analysis
  • 10.3. Market Size & Forecasts Trend Analysis, 2021 to 2033
  • 10.4. North America
    • 10.4.1. North America Recombinant Vaccine CDMO Market Estimates & Forecasts, By Country, 2021-2033 (USD Billion)
    • 10.4.2. U.S.
      • 10.4.2.1. Key Country Dynamics
      • 10.4.2.2. Regulatory Framework
      • 10.4.2.3. U.S. Recombinant Vaccine CDMO Market Estimates & Forecasts, 2021-2033 (USD Billion)
    • 10.4.3. Canada
      • 10.4.3.1. Key Country Dynamics
      • 10.4.3.2. Regulatory Framework
      • 10.4.3.3. Canada Recombinant Vaccine CDMO Market Estimates & Forecasts, 2021-2033 (USD Billion)
    • 10.4.4. Mexico
      • 10.4.4.1. Key Country Dynamics
      • 10.4.4.2. Regulatory Framework
      • 10.4.4.3. Mexico Recombinant Vaccine CDMO Market Estimates & Forecasts, 2021-2033 (USD Billion)
  • 10.5. Europe
    • 10.5.1. Europe Recombinant Vaccine CDMO Market Estimates & Forecasts, 2021-2033 (USD Billion)
    • 10.5.2. UK
      • 10.5.2.1. Key Country Dynamics
      • 10.5.2.2. Regulatory Framework
      • 10.5.2.3. UK Recombinant Vaccine CDMO Market Estimates & Forecasts, 2021-2033 (USD Billion)
    • 10.5.3. Germany
      • 10.5.3.1. Key Country Dynamics
      • 10.5.3.2. Regulatory Framework
      • 10.5.3.3. Germany Recombinant Vaccine CDMO Market Estimates & Forecasts, 2021-2033 (USD Billion)
    • 10.5.4. France
      • 10.5.4.1. Key Country Dynamics
      • 10.5.4.2. Regulatory Framework
      • 10.5.4.3. France Recombinant Vaccine CDMO Market Estimates & Forecasts, 2021-2033 (USD Billion)
    • 10.5.5. Italy
      • 10.5.5.1. Key Country Dynamics
      • 10.5.5.2. Regulatory Framework
      • 10.5.5.3. Italy Recombinant Vaccine CDMO Market Estimates & Forecasts, 2021-2033 (USD Billion)
    • 10.5.6. Spain
      • 10.5.6.1. Key Country Dynamics
      • 10.5.6.2. Regulatory Framework
      • 10.5.6.3. Spain Recombinant Vaccine CDMO Market Estimates & Forecasts, 2021-2033 (USD Billion)
    • 10.5.7. Denmark
      • 10.5.7.1. Key Country Dynamics
      • 10.5.7.2. Regulatory Framework
      • 10.5.7.3. Denmark Recombinant Vaccine CDMO Market Estimates & Forecasts, 2021-2033 (USD Billion)
    • 10.5.8. Sweden
      • 10.5.8.1. Key Country Dynamics
      • 10.5.8.2. Regulatory Framework
      • 10.5.8.3. Sweden Recombinant Vaccine CDMO Market Estimates & Forecasts, 2021-2033 (USD Billion)
    • 10.5.9. Norway
      • 10.5.9.1. Key Country Dynamics
      • 10.5.9.2. Regulatory Framework
      • 10.5.9.3. Norway Recombinant Vaccine CDMO Market Estimates & Forecasts, 2021-2033 (USD Billion)
  • 10.6. Asia Pacific
    • 10.6.1. Asia Pacific Recombinant Vaccine CDMO Market Estimates & Forecasts, 2021-2033 (USD Billion)
    • 10.6.2. Japan
      • 10.6.2.1. Key Country Dynamics
      • 10.6.2.2. Regulatory Framework
      • 10.6.2.3. Japan Recombinant Vaccine CDMO Market Estimates & Forecasts, 2021-2033 (USD Billion)
    • 10.6.3. China
      • 10.6.3.1. Key Country Dynamics
      • 10.6.3.2. Regulatory Framework
      • 10.6.3.3. China Recombinant Vaccine CDMO Market Estimates & Forecasts, 2021-2033 (USD Billion)
    • 10.6.4. India
      • 10.6.4.1. Key Country Dynamics
      • 10.6.4.2. Regulatory Framework
      • 10.6.4.3. India Recombinant Vaccine CDMO Market Estimates & Forecasts, 2021-2033 (USD Billion)
    • 10.6.5. Australia
      • 10.6.5.1. Key Country Dynamics
      • 10.6.5.2. Regulatory Framework
      • 10.6.5.3. Australia Recombinant Vaccine CDMO Market Estimates & Forecasts, 2021-2033 (USD Billion)
    • 10.6.6. South Korea
      • 10.6.6.1. Key Country Dynamics
      • 10.6.6.2. Regulatory Framework
      • 10.6.6.3. South Korea Recombinant Vaccine CDMO Market Estimates & Forecasts, 2021-2033 (USD Billion)
    • 10.6.7. Thailand
      • 10.6.7.1. Key Country Dynamics
      • 10.6.7.2. Regulatory Framework
      • 10.6.7.3. Thailand Recombinant Vaccine CDMO Market Estimates & Forecasts, 2021-2033 (USD Billion)
  • 10.7. Latin America
    • 10.7.1. Latin America Recombinant Vaccine CDMO Market Estimates & Forecasts, 2021-2033 (USD Billion)
    • 10.7.2. Brazil
      • 10.7.2.1. Key Country Dynamics
      • 10.7.2.2. Regulatory Framework
      • 10.7.2.3. Brazil Recombinant Vaccine CDMO Market Estimates & Forecasts, 2021-2033 (USD Billion)
    • 10.7.3. Argentina
      • 10.7.3.1. Key Country Dynamics
      • 10.7.3.2. Regulatory Framework
      • 10.7.3.3. Argentina Recombinant Vaccine CDMO Market Estimates & Forecasts, 2021-2033 (USD Billion)
  • 10.8. Middle East and Africa
    • 10.8.1. Middle East and Africa Recombinant Vaccine CDMO Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
    • 10.8.2. South Africa
      • 10.8.2.1. Key Country Dynamics
      • 10.8.2.2. Regulatory Framework
      • 10.8.2.3. South Africa Recombinant Vaccine CDMO Market Estimates & Forecasts, 2021-2033 (USD Billion)
    • 10.8.3. Saudi Arabia
      • 10.8.3.1. Key Country Dynamics
      • 10.8.3.2. Regulatory Framework
      • 10.8.3.3. Saudi Arabia Recombinant Vaccine CDMO Market Estimates & Forecasts, 2021-2033 (USD Billion)
    • 10.8.4. UAE
      • 10.8.4.1. Key Country Dynamics
      • 10.8.4.2. Regulatory Framework
      • 10.8.4.3. UAE Recombinant Vaccine CDMO Market Estimates & Forecasts, 2021-2033 (USD Billion)
    • 10.8.5. Kuwait
      • 10.8.5.1. Key Country Dynamics
      • 10.8.5.2. Regulatory Framework
      • 10.8.5.3. Kuwait Recombinant Vaccine CDMO Market Estimates & Forecasts, 2021-2033 (USD Billion)
    • 10.8.6. Oman
      • 10.8.6.1. Key Country Dynamics
      • 10.8.6.2. Regulatory Framework
      • 10.8.6.3. Oman Recombinant Vaccine CDMO Market Estimates & Forecasts, 2021-2033 (USD Billion)
    • 10.8.7. Qatar
      • 10.8.7.1. Key Country Dynamics
      • 10.8.7.2. Regulatory Framework
      • 10.8.7.3. Qatar Recombinant Vaccine CDMO Market Estimates & Forecasts, 2021-2033 (USD Billion)

Chapter 11. Competitive Landscape

  • 11.1. Participant Overview
  • 11.2. Company Market Position Analysis
  • 11.3. Company Categorization
  • 11.4. Strategy Mapping
  • 11.5. Company Profiles/Listing
    • 11.5.1. FUJIFILM Biotechnologies
      • 11.5.1.1. Company overview
      • 11.5.1.2. Financial performance
      • 11.5.1.3. Service benchmarking
      • 11.5.1.4. Strategic initiatives
    • 11.5.2. WuXi Biologics
      • 11.5.2.1. Company overview
      • 11.5.2.2. Financial performance
      • 11.5.2.3. Service benchmarking
      • 11.5.2.4. Strategic initiatives
    • 11.5.3. IDT Biologika
      • 11.5.3.1. Company overview
      • 11.5.3.2. Financial performance
      • 11.5.3.3. Service benchmarking
      • 11.5.3.4. Strategic initiatives
    • 11.5.4. Lonza
      • 11.5.4.1. Company overview
      • 11.5.4.2. Financial performance
      • 11.5.4.3. Service benchmarking
      • 11.5.4.4. Strategic initiatives
    • 11.5.5. Thermo Fisher Scientific (Patheon)
      • 11.5.5.1. Company overview
      • 11.5.5.2. Financial performance
      • 11.5.5.3. Service benchmarking
      • 11.5.5.4. Strategic initiatives
    • 11.5.6. AGC Biologics
      • 11.5.6.1. Company overview
      • 11.5.6.2. Financial performance
      • 11.5.6.3. Service benchmarking
      • 11.5.6.4. Strategic initiatives
    • 11.5.7. KBI Biopharma
      • 11.5.7.1. Company overview
      • 11.5.7.2. Financial performance
      • 11.5.7.3. Service benchmarking
      • 11.5.7.4. Strategic initiatives
    • 11.5.8. Ajinomoto Bio-Pharma Services
      • 11.5.8.1. Company overview
      • 11.5.8.2. Financial performance
      • 11.5.8.3. Service benchmarking
      • 11.5.8.4. Strategic initiatives
    • 11.5.9. Northway Biotech
      • 11.5.9.1. Company overview
      • 11.5.9.2. Financial performance
      • 11.5.9.3. Service benchmarking
      • 11.5.9.4. Strategic initiatives
    • 11.5.10. Batavia Biosciences
      • 11.5.10.1. Company overview
      • 11.5.10.2. Financial performance
      • 11.5.10.3. Service benchmarking
      • 11.5.10.4. Strategic initiatives
    • 11.5.11. Recipharm
      • 11.5.11.1. Company overview
      • 11.5.11.2. Financial performance
      • 11.5.11.3. Service benchmarking
      • 11.5.11.4. Strategic initiatives
    • 11.5.12. 3P Biopharmaceuticals
      • 11.5.12.1. Company overview
      • 11.5.12.2. Financial performance
      • 11.5.12.3. Service benchmarking
      • 11.5.12.4. Strategic initiatives
    • 11.5.13. Biofabri
      • 11.5.13.1. Company overview
      • 11.5.13.2. Financial performance
      • 11.5.13.3. Service benchmarking
      • 11.5.13.4. Strategic initiatives
    • 11.5.14. Biological E. Limited
      • 11.5.14.1. Company overview
      • 11.5.14.2. Financial performance
      • 11.5.14.3. Service benchmarking
      • 11.5.14.4. Strategic initiatives
    • 11.5.15. SK bioscience
      • 11.5.15.1. Company overview
      • 11.5.15.2. Financial performance
      • 11.5.15.3. Service benchmarking
      • 11.5.15.4. Strategic initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Recombinant Vaccine CDMO Market Estimates and Forecasts, by Vaccine, 2021 - 2033 (USD Billion)
  • Table 4 Global Recombinant Vaccine CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Billion)
  • Table 5 Global Recombinant Vaccine CDMO Market Estimates and Forecasts, by Expression Platform, 2021 - 2033 (USD Billion)
  • Table 6 Global Recombinant Vaccine CDMO Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Billion)
  • Table 7 Global Recombinant Vaccine CDMO Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Billion)
  • Table 8 Global Recombinant Vaccine CDMO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Billion)
  • Table 9 North America Recombinant Vaccine CDMO Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Billion)
  • Table 10 North America Recombinant Vaccine CDMO Market Estimates and Forecasts, by Vaccine, 2021 - 2033 (USD Billion)
  • Table 11 North America Recombinant Vaccine CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Billion)
  • Table 12 North America Recombinant Vaccine CDMO Market Estimates and Forecasts, by Expression Platform, 2021 - 2033 (USD Billion)
  • Table 13 North America Recombinant Vaccine CDMO Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Billion)
  • Table 14 North America Recombinant Vaccine CDMO Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Billion)
  • Table 15 North America Recombinant Vaccine CDMO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Billion)
  • Table 16 U.S. Recombinant Vaccine CDMO Market Estimates and Forecasts, by Vaccine, 2021 - 2033 (USD Billion)
  • Table 17 U.S.Recombinant Vaccine CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Billion)
  • Table 18 U.S. Recombinant Vaccine CDMO Market Estimates and Forecasts, by Expression Platform, 2021 - 2033 (USD Billion)
  • Table 19 U.S. Recombinant Vaccine CDMO Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Billion)
  • Table 20 U.S. Recombinant Vaccine CDMO Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Billion)
  • Table 21 U.S. Recombinant Vaccine CDMO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Billion)
  • Table 22 Canada Recombinant Vaccine CDMO Market Estimates and Forecasts, by Vaccine, 2021 - 2033 (USD Billion)
  • Table 23 Canada Recombinant Vaccine CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Billion)
  • Table 24 Canada Recombinant Vaccine CDMO Market Estimates and Forecasts, by Expression Platform, 2021 - 2033 (USD Billion)
  • Table 25 Canada Recombinant Vaccine CDMO Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Billion)
  • Table 26 Canada Recombinant Vaccine CDMO Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Billion)
  • Table 27 Canada Recombinant Vaccine CDMO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Billion)
  • Table 28 Mexico Recombinant Vaccine CDMO Market Estimates and Forecasts, by Vaccine, 2021 - 2033 (USD Billion)
  • Table 29 Mexico Recombinant Vaccine CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Billion)
  • Table 30 Mexico Recombinant Vaccine CDMO Market Estimates and Forecasts, by Expression Platform, 2021 - 2033 (USD Billion)
  • Table 31 Mexico Recombinant Vaccine CDMO Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Billion)
  • Table 32 Mexico Recombinant Vaccine CDMO Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Billion)
  • Table 33 Mexico Recombinant Vaccine CDMO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Billion)
  • Table 34 Europe Recombinant Vaccine CDMO Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Billion)
  • Table 35 Europe Recombinant Vaccine CDMO Market Estimates and Forecasts, by Vaccine, 2021 - 2033 (USD Billion)
  • Table 36 Europe Recombinant Vaccine CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Billion)
  • Table 37 Europe Recombinant Vaccine CDMO Market Estimates and Forecasts, by Expression Platform, 2021 - 2033 (USD Billion)
  • Table 38 Europe Recombinant Vaccine CDMO Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Billion)
  • Table 39 Europe Recombinant Vaccine CDMO Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Billion)
  • Table 40 Europe Recombinant Vaccine CDMO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Billion)
  • Table 41 UK Recombinant Vaccine CDMO Market Estimates and Forecasts, by Vaccine, 2021 - 2033 (USD Billion)
  • Table 42 UK Recombinant Vaccine CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Billion)
  • Table 43 UK Recombinant Vaccine CDMO Market Estimates and Forecasts, by Expression Platform, 2021 - 2033 (USD Billion)
  • Table 44 UK Recombinant Vaccine CDMO Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Billion)
  • Table 45 UK Recombinant Vaccine CDMO Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Billion)
  • Table 46 UK Recombinant Vaccine CDMO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Billion)
  • Table 47 Germany Recombinant Vaccine CDMO Market Estimates and Forecasts, by Vaccine, 2021 - 2033 (USD Billion)
  • Table 48 Germany Recombinant Vaccine CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Billion)
  • Table 49 Germany Recombinant Vaccine CDMO Market Estimates and Forecasts, by Expression Platform, 2021 - 2033 (USD Billion)
  • Table 50 Germany Recombinant Vaccine CDMO Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Billion)
  • Table 51 Germany Recombinant Vaccine CDMO Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Billion)
  • Table 52 Germany Recombinant Vaccine CDMO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Billion)
  • Table 53 France Recombinant Vaccine CDMO Market Estimates and Forecasts, by Vaccine, 2021 - 2033 (USD Billion)
  • Table 54 France Recombinant Vaccine CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Billion)
  • Table 55 France Recombinant Vaccine CDMO Market Estimates and Forecasts, by Expression Platform, 2021 - 2033 (USD Billion)
  • Table 56 France Recombinant Vaccine CDMO Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Billion)
  • Table 57 France Recombinant Vaccine CDMO Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Billion)
  • Table 58 France Recombinant Vaccine CDMO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Billion)
  • Table 59 Italy Recombinant Vaccine CDMO Market Estimates and Forecasts, by Vaccine, 2021 - 2033 (USD Billion)
  • Table 60 Italy Recombinant Vaccine CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Billion)
  • Table 61 Italy Recombinant Vaccine CDMO Market Estimates and Forecasts, by Expression Platform, 2021 - 2033 (USD Billion)
  • Table 62 Italy Recombinant Vaccine CDMO Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Billion)
  • Table 63 Italy Recombinant Vaccine CDMO Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Billion)
  • Table 64 Italy Recombinant Vaccine CDMO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Billion)
  • Table 65 Spain Recombinant Vaccine CDMO Market Estimates and Forecasts, by Vaccine, 2021 - 2033 (USD Billion)
  • Table 66 Spain Recombinant Vaccine CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Billion)
  • Table 67 Spain Recombinant Vaccine CDMO Market Estimates and Forecasts, by Expression Platform, 2021 - 2033 (USD Billion)
  • Table 68 Spain Recombinant Vaccine CDMO Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Billion)
  • Table 69 Spain Recombinant Vaccine CDMO Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Billion)
  • Table 70 Spain Recombinant Vaccine CDMO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Billion)
  • Table 71 Denmark Recombinant Vaccine CDMO Market Estimates and Forecasts, by Vaccine, 2021 - 2033 (USD Billion)
  • Table 72 Denmark Recombinant Vaccine CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Billion)
  • Table 73 Denmark Recombinant Vaccine CDMO Market Estimates and Forecasts, by Expression Platform, 2021 - 2033 (USD Billion)
  • Table 74 Denmark Recombinant Vaccine CDMO Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Billion)
  • Table 75 Denmark Recombinant Vaccine CDMO Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Billion)
  • Table 76 Denmark Recombinant Vaccine CDMO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Billion)
  • Table 77 Sweden Recombinant Vaccine CDMO Market Estimates and Forecasts, by Vaccine, 2021 - 2033 (USD Billion)
  • Table 78 Sweden Recombinant Vaccine CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Billion)
  • Table 79 Sweden Recombinant Vaccine CDMO Market Estimates and Forecasts, by Expression Platform, 2021 - 2033 (USD Billion)
  • Table 80 Sweden Recombinant Vaccine CDMO Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Billion)
  • Table 81 Sweden Recombinant Vaccine CDMO Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Billion)
  • Table 82 Sweden Recombinant Vaccine CDMO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Billion)
  • Table 83 Norway Recombinant Vaccine CDMO Market Estimates and Forecasts, by Vaccine, 2021 - 2033 (USD Billion)
  • Table 84 Norway Recombinant Vaccine CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Billion)
  • Table 85 Norway Recombinant Vaccine CDMO Market Estimates and Forecasts, by Expression Platform, 2021 - 2033 (USD Billion)
  • Table 86 Norway Recombinant Vaccine CDMO Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Billion)
  • Table 87 Norway Recombinant Vaccine CDMO Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Billion)
  • Table 88 Norway Recombinant Vaccine CDMO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Billion)
  • Table 89 Asia Pacific Recombinant Vaccine CDMO Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Billion)
  • Table 90 Asia Pacific Recombinant Vaccine CDMO Market Estimates and Forecasts, by Vaccine, 2021 - 2033 (USD Billion)
  • Table 91 Asia Pacific Recombinant Vaccine CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Billion)
  • Table 92 Asia Pacific Recombinant Vaccine CDMO Market Estimates and Forecasts, by Expression Platform, 2021 - 2033 (USD Billion)
  • Table 93 Asia Pacific Recombinant Vaccine CDMO Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Billion)
  • Table 94 Asia Pacific Recombinant Vaccine CDMO Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Billion)
  • Table 95 Asia Pacific Recombinant Vaccine CDMO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Billion)
  • Table 96 Japan Recombinant Vaccine CDMO Market Estimates and Forecasts, by Vaccine, 2021 - 2033 (USD Billion)
  • Table 97 Japan Recombinant Vaccine CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Billion)
  • Table 98 Japan Recombinant Vaccine CDMO Market Estimates and Forecasts, by Expression Platform, 2021 - 2033 (USD Billion)
  • Table 99 Japan Recombinant Vaccine CDMO Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Billion)
  • Table 100 Japan Recombinant Vaccine CDMO Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Billion)
  • Table 101 Japan Recombinant Vaccine CDMO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Billion)
  • Table 102 China Recombinant Vaccine CDMO Market Estimates and Forecasts, by Vaccine, 2021 - 2033 (USD Billion)
  • Table 103 China Recombinant Vaccine CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Billion)
  • Table 104 China Recombinant Vaccine CDMO Market Estimates and Forecasts, by Expression Platform, 2021 - 2033 (USD Billion)
  • Table 105 China Recombinant Vaccine CDMO Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Billion)
  • Table 106 China Recombinant Vaccine CDMO Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Billion)
  • Table 107 China Recombinant Vaccine CDMO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Billion)
  • Table 108 India Recombinant Vaccine CDMO Market Estimates and Forecasts, by Vaccine, 2021 - 2033 (USD Billion)
  • Table 109 India Recombinant Vaccine CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Billion)
  • Table 110 India Recombinant Vaccine CDMO Market Estimates and Forecasts, by Expression Platform, 2021 - 2033 (USD Billion)
  • Table 111 India Recombinant Vaccine CDMO Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Billion)
  • Table 112 India Recombinant Vaccine CDMO Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Billion)
  • Table 113 India Recombinant Vaccine CDMO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Billion)
  • Table 114 Australia Recombinant Vaccine CDMO Market Estimates and Forecasts, by Vaccine, 2021 - 2033 (USD Billion)
  • Table 115 Australia Recombinant Vaccine CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Billion)
  • Table 116 Australia Recombinant Vaccine CDMO Market Estimates and Forecasts, by Expression Platform, 2021 - 2033 (USD Billion)
  • Table 117 Australia Recombinant Vaccine CDMO Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Billion)
  • Table 118 Australia Recombinant Vaccine CDMO Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Billion)
  • Table 119 Australia Recombinant Vaccine CDMO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Billion)
  • Table 120 Thailand Recombinant Vaccine CDMO Market Estimates and Forecasts, by Vaccine, 2021 - 2033 (USD Billion)
  • Table 121 Thailand Recombinant Vaccine CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Billion)
  • Table 122 Thailand Recombinant Vaccine CDMO Market Estimates and Forecasts, by Expression Platform, 2021 - 2033 (USD Billion)
  • Table 123 Thailand Recombinant Vaccine CDMO Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Billion)
  • Table 124 Thailand Recombinant Vaccine CDMO Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Billion)
  • Table 125 Thailand Recombinant Vaccine CDMO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Billion)
  • Table 126 South Korea Recombinant Vaccine CDMO Market Estimates and Forecasts, by Vaccine, 2021 - 2033 (USD Billion)
  • Table 127 South Korea Recombinant Vaccine CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Billion)
  • Table 128 South Korea Recombinant Vaccine CDMO Market Estimates and Forecasts, by Expression Platform, 2021 - 2033 (USD Billion)
  • Table 129 South Korea Recombinant Vaccine CDMO Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Billion)
  • Table 130 South Korea Recombinant Vaccine CDMO Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Billion)
  • Table 131 South Korea Recombinant Vaccine CDMO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Billion)
  • Table 132 Latin America Recombinant Vaccine CDMO Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Billion)
  • Table 133 Latin America Recombinant Vaccine CDMO Market Estimates and Forecasts, by Vaccine, 2021 - 2033 (USD Billion)
  • Table 134 Latin America Recombinant Vaccine CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Billion)
  • Table 135 Latin America Recombinant Vaccine CDMO Market Estimates and Forecasts, by Expression Platform, 2021 - 2033 (USD Billion)
  • Table 136 Latin America Recombinant Vaccine CDMO Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Billion)
  • Table 137 Latin America Recombinant Vaccine CDMO Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Billion)
  • Table 138 Latin America Recombinant Vaccine CDMO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Billion)
  • Table 139 Brazil Recombinant Vaccine CDMO Market Estimates and Forecasts, by Vaccine, 2021 - 2033 (USD Billion)
  • Table 140 Brazil Recombinant Vaccine CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Billion)
  • Table 141 Brazil Recombinant Vaccine CDMO Market Estimates and Forecasts, by Expression Platform, 2021 - 2033 (USD Billion)
  • Table 142 Brazil Recombinant Vaccine CDMO Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Billion)
  • Table 143 Brazil Recombinant Vaccine CDMO Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Billion)
  • Table 144 Brazil Recombinant Vaccine CDMO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Billion)
  • Table 145 Argentina Recombinant Vaccine CDMO Market Estimates and Forecasts, by Vaccine, 2021 - 2033 (USD Billion)
  • Table 146 Argentina Recombinant Vaccine CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Billion)
  • Table 147 Argentina Recombinant Vaccine CDMO Market Estimates and Forecasts, by Expression Platform, 2021 - 2033 (USD Billion)
  • Table 148 Argentina Recombinant Vaccine CDMO Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Billion)
  • Table 149 Argentina Recombinant Vaccine CDMO Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Billion)
  • Table 150 Argentina Recombinant Vaccine CDMO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Billion)
  • Table 151 Middle East & Africa Recombinant Vaccine CDMO Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Billion)
  • Table 152 Middle East & Africa Recombinant Vaccine CDMO Market Estimates and Forecasts, by Vaccine, 2021 - 2033 (USD Billion)
  • Table 153 Middle East & Africa Recombinant Vaccine CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Billion)
  • Table 154 Middle East & Africa Recombinant Vaccine CDMO Market Estimates and Forecasts, by Expression Platform, 2021 - 2033 (USD Billion)
  • Table 155 Middle East & Africa Recombinant Vaccine CDMO Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Billion)
  • Table 156 Middle East & Africa Recombinant Vaccine CDMO Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Billion)
  • Table 157 Middle East & Africa Recombinant Vaccine CDMO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Billion)
  • Table 158 South Africa Recombinant Vaccine CDMO Market Estimates and Forecasts, by Vaccine, 2021 - 2033 (USD Billion)
  • Table 159 South Africa Recombinant Vaccine CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Billion)
  • Table 160 South Africa Recombinant Vaccine CDMO Market Estimates and Forecasts, by Expression Platform, 2021 - 2033 (USD Billion)
  • Table 161 South Africa Recombinant Vaccine CDMO Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Billion)
  • Table 162 South Africa Recombinant Vaccine CDMO Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Billion)
  • Table 163 South Africa Recombinant Vaccine CDMO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Billion)
  • Table 164 Saudi Arabia Recombinant Vaccine CDMO Market Estimates and Forecasts, by Vaccine, 2021 - 2033 (USD Billion)
  • Table 165 Saudi Arabia Recombinant Vaccine CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Billion)
  • Table 166 Saudi Arabia Recombinant Vaccine CDMO Market Estimates and Forecasts, by Expression Platform, 2021 - 2033 (USD Billion)
  • Table 167 Saudi Arabia Recombinant Vaccine CDMO Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Billion)
  • Table 168 Saudi Arabia Recombinant Vaccine CDMO Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Billion)
  • Table 169 Saudi Arabia Recombinant Vaccine CDMO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Billion)
  • Table 170 UAE Recombinant Vaccine CDMO Market Estimates and Forecasts, by Vaccine, 2021 - 2033 (USD Billion)
  • Table 171 UAE Recombinant Vaccine CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Billion)
  • Table 172 UAE Recombinant Vaccine CDMO Market Estimates and Forecasts, by Expression Platform, 2021 - 2033 (USD Billion)
  • Table 173 UAE Recombinant Vaccine CDMO Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Billion)
  • Table 174 UAE Recombinant Vaccine CDMO Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Billion)
  • Table 175 UAE Recombinant Vaccine CDMO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Billion)
  • Table 176 Kuwait Recombinant Vaccine CDMO Market Estimates and Forecasts, by Vaccine, 2021 - 2033 (USD Billion)
  • Table 177 Kuwait Recombinant Vaccine CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Billion)
  • Table 178 Kuwait Recombinant Vaccine CDMO Market Estimates and Forecasts, by Expression Platform, 2021 - 2033 (USD Billion)
  • Table 179 Kuwait Recombinant Vaccine CDMO Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Billion)
  • Table 180 Kuwait Recombinant Vaccine CDMO Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Billion)
  • Table 181 Kuwait Recombinant Vaccine CDMO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Billion)
  • Table 182 Oman Recombinant Vaccine CDMO Market Estimates and Forecasts, by Vaccine, 2021 - 2033 (USD Billion)
  • Table 183 Oman Recombinant Vaccine CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Billion)
  • Table 184 Oman Recombinant Vaccine CDMO Market Estimates and Forecasts, by Expression Platform, 2021 - 2033 (USD Billion)
  • Table 185 Oman Recombinant Vaccine CDMO Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Billion)
  • Table 186 Oman Recombinant Vaccine CDMO Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Billion)
  • Table 187 Oman Recombinant Vaccine CDMO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Billion)
  • Table 188 Qatar Recombinant Vaccine CDMO Market Estimates and Forecasts, by Vaccine, 2021 - 2033 (USD Billion)
  • Table 189 Qatar Recombinant Vaccine CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Billion)
  • Table 190 Qatar Recombinant Vaccine CDMO Market Estimates and Forecasts, by Expression Platform, 2021 - 2033 (USD Billion)
  • Table 191 Qatar Recombinant Vaccine CDMO Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Billion)
  • Table 192 Qatar Recombinant Vaccine CDMO Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Billion)
  • Table 193 Qatar Recombinant Vaccine CDMO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Billion)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Market formulation & validation
  • Fig. 6 Commodity flow analysis
  • Fig. 7 Value-chain-based sizing & forecasting
  • Fig. 8 QFD model sizing & forecasting
  • Fig. 9 Bottom-up approach
  • Fig. 10 Market snapshot
  • Fig. 11 Segment snapshot 1
  • Fig. 12 Segment snapshot 2
  • Fig. 13 Competitive landscape snapshot
  • Fig. 14 Parent market outlook, 2025 (USD Billion)
  • Fig. 15 Ancillary market outlook, 2025 (USD Billion)
  • Fig. 16 Recombinant Vaccine CDMO Market Dynamics
  • Fig. 17 Porter's five forces analysis
  • Fig. 18 PESTEL analysis
  • Fig. 19 Recombinant Vaccine CDMO Market: Vaccine outlook and key takeaways
  • Fig. 20 Recombinant Vaccine CDMO Market: Vaccine movement analysis
  • Fig. 21 Recombinant Protein/Subunit Vaccines Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 22 Virus-Like Particle (VLP) Vaccines Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 23 Recombinant Viral Vector Vaccines Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 24 Recombinant DNA/mRNA-enabled Vaccines Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 25 Others Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 26 Recombinant Vaccine CDMO Market: Service outlook and key takeaways
  • Fig. 27 Recombinant Vaccine CDMO Market: Service movement analysis
  • Fig. 28 Contract Development Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 29 Cell Line Development Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 30 Process Development & Optimization Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 31 Analytical Testing & Method Validation Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 32 Scale-up & Tech Transfer Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 33 Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 34 API Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 35 Finished Drug Products Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 36 Packaging and Labeling Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 37 Regulatory Affairs Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 38 Others Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 39 Recombinant Vaccine CDMO Market: Expression Platform outlook and key takeaways
  • Fig. 40 Recombinant Vaccine CDMO Market: Expression Platform movement analysis
  • Fig. 41 Mammalian Cell Expression Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 42 Microbial Expression Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 43 Cell-Based Expression Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 44 Plant-Based Expression Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 45 Others Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 46 Recombinant Vaccine CDMO Market: Workflow outlook and key takeaways
  • Fig. 47 Recombinant Vaccine CDMO Market: Workflow movement analysis
  • Fig. 48 Clinical Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 49 Commercial Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 50 Recombinant Vaccine CDMO Market: Therapeutic Area outlook and key takeaways
  • Fig. 51 Recombinant Vaccine CDMO Market: Therapeutic Area movement analysis
  • Fig. 52 Infectious Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 53 Oncology Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 54 Neurological Disorders Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 55 Other Applications Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 56 Recombinant Vaccine CDMO Market: End Use outlook and key takeaways
  • Fig. 57 Recombinant Vaccine CDMO Market: End Use movement analysis
  • Fig. 58 Pharmaceutical Companies Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 59 Biotechnology Companies Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 60 Academic and Research Institutions Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 61 Others Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 62 Regional Marketplace: Key Takeaways
  • Fig. 63 North America Recombinant Vaccine CDMO Market Estimates and Forecasts, 2018-2030 (USD Billion)
  • Fig. 64 Key country dynamics
  • Fig. 65 U.S. Recombinant Vaccine CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 66 Key country dynamics
  • Fig. 67 Canada Recombinant Vaccine CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 68 Key country dynamics
  • Fig. 69 Mexico Recombinant Vaccine CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 70 Europe Recombinant Vaccine CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 71 Key country dynamics
  • Fig. 72 UK Recombinant Vaccine CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 73 Key country dynamics
  • Fig. 74 Germany Recombinant Vaccine CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 75 Key country dynamics
  • Fig. 76 France Recombinant Vaccine CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 77 Key country dynamics
  • Fig. 78 Italy Recombinant Vaccine CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 79 Key country dynamics
  • Fig. 80 Spain Recombinant Vaccine CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 81 Key country dynamics
  • Fig. 82 Denmark Recombinant Vaccine CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 83 Key country dynamics
  • Fig. 84 Sweden Recombinant Vaccine CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 85 Key country dynamics
  • Fig. 86 Norway Recombinant Vaccine CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 87 Asia Pacific Recombinant Vaccine CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 88 Key country dynamics
  • Fig. 89 Japan Recombinant Vaccine CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 90 Key country dynamics
  • Fig. 91 China Recombinant Vaccine CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 92 Key country dynamics
  • Fig. 93 India Recombinant Vaccine CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 94 Key country dynamics
  • Fig. 95 Australia Recombinant Vaccine CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 96 Key country dynamics
  • Fig. 97 Thailand Recombinant Vaccine CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 98 Key country dynamics
  • Fig. 99 South Korea Recombinant Vaccine CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 100 Latin America Recombinant Vaccine CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 101 Key country dynamics
  • Fig. 102 Brazil Recombinant Vaccine CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 103 Key country dynamics
  • Fig. 104 Argentina Recombinant Vaccine CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 105 MEA Recombinant Vaccine CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 106 Key country dynamics
  • Fig. 107 South Africa Recombinant Vaccine CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 108 Key country dynamics
  • Fig. 109 UAE Recombinant Vaccine CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 110 Key country dynamics
  • Fig. 111 Saudi Arabia Recombinant Vaccine CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 112 Key country dynamics
  • Fig. 113 Kuwait Recombinant Vaccine CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 114 Key country dynamics
  • Fig. 115 Qatar Recombinant Vaccine CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 116 Key country dynamics
  • Fig. 117 Oman Recombinant Vaccine CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 118 Key country dynamics
  • Fig. 119 Participant Categorization
  • Fig. 120 Company Market Position Analysis
  • Fig. 121 Strategic Framework